Drug General Information (ID: DDII62CADZ)
  Drug Name Pimozide Drug Info Edetate disodium anhydrous Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antipsychotic Agents Chelating Agents
  Structure

 Mechanism of Pimozide-Edetate disodium anhydrous Interaction (Severity Level: Major)
     Increased risk of ventricular arrhythmias Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Pimozide Edetate disodium anhydrous
      Mechanism 1 Prolong QT interval Hypokalemia
      Key Mechanism Factor 1
Factor Name Ventricular arrhythmias
Factor Description Ventricular arrhythmias are abnormal heart rhythms that cause your heart's lower chambers to pump blood instead of pumping it. This can limit or stop your heart from supplying blood to your body. While some of these arrhythmias are harmless and do not cause symptoms, others can have serious, even fatal, effects on your body.
      Mechanism Description
  • Increased risk of ventricular arrhythmias by the combination of Pimozide and Edetate disodium anhydrous 
      Mechanism 2 Prolong QT interval Hypomagnesemia
      Key Mechanism Factor 2
Factor Name Ventricular arrhythmias
Factor Description Ventricular arrhythmias are abnormal heart rhythms that cause your heart's lower chambers to pump blood instead of pumping it. This can limit or stop your heart from supplying blood to your body. While some of these arrhythmias are harmless and do not cause symptoms, others can have serious, even fatal, effects on your body.
      Mechanism Description
  • Increased risk of ventricular arrhythmias by the combination of Pimozide and Edetate disodium anhydrous 

Recommended Action
      Management Caution is advised when pimozide must be used concomitantly with medications that can cause potassium and/or magnesium disturbances. Serum electrolytes should be monitored and any abnormalities corrected prior to initiating therapy with pimozide.

References
1 Dresser GK, Spence JD, Bailey DG "Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition." Clin Pharmacokinet 38 (2000): 41-57. [PMID: 10668858]
2 Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.